Home›Search›Clinical Lymphoma, Myeloma and Leukemia

Clinical Lymphoma, Myeloma and Leukemia

Elsevier Inc. · United States · Est. 1907

ISSN2152-2650eISSN2152-2669

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (2 more)+12

Total90

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.615

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.647

Total Worksi

16,571

Total Citationsi

44,514

2yr Mean Citednessi

0.27

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Clinical Lymphoma, Myeloma and Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1907

Annual Volume~ 2,559 articles / year

StatusActive (last: 2026)

Total Publications16,571

Publisher OrgElsevier BV

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Elsevier Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2152-2650 / 2152-2669

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.3k

4.7k

2019

702

3.7k

2020

1.4k

3.3k

2021

1.6k

1.8k

2022

1.6k

2023

2.2k

1.3k

2024

3.5k

595

2025

119

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ2

Cancer ResearchQ3

OncologyQ3

Subject Classification

Web of Science Categories

HematologyOncology

Scopus Categories

HematologyCancer ResearchOncology

Research Topics (OpenAlex)

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchMyeloproliferative Neoplasms: Diagnosis and TreatmentCAR-T cell therapy researchProtein Degradation and InhibitorsCancer Treatment and Pharmacology

Frequently asked questions about Clinical Lymphoma, Myeloma and Leukemia

Is Clinical Lymphoma, Myeloma and Leukemia a predatory journal?

PubScope has no integrity flags on record for Clinical Lymphoma, Myeloma and Leukemia: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Clinical Lymphoma, Myeloma and Leukemia?

Clinical Lymphoma, Myeloma and Leukemia is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.27.

Is Clinical Lymphoma, Myeloma and Leukemia indexed in Scopus and Web of Science?

Clinical Lymphoma, Myeloma and Leukemia is indexed in Web of Science, Scopus.